Summary.-Thirty-two variables at diagnosis of acute lymphoblastic leukaemia (ALL) were studied in an unselected population-based series of 209 children. Twelve variables had individually a statistically significant effect on the duration of first remission. A multivariate analysis using data on the 199 children who went into complete remission showed that all significant variation in remission times could be explained by only 3 variables acting simultaneously. These were the total white blood count (WBC) at diagnosis, the Franco-American-British (FAB) classification of blast morphology and the percentage of lymphoblasts with PAS+ coarse granules or blocks. A simple scoring system (for WBC add 1 if <20 x 109/1, add 2 if 20-50 x 109/1, add 3 if >50 x 109/1; for L2 or L3 leukaemia add 1; for PAS+ <5% add 1) separated patients into risk groups with widely different median lengths of first remission. Application of the risk score improves the prediction of the outcome of treatment, and in clinical trials, allows more accurate stratification, less extensive data collection and simpler analysis.
THERE HAVE BEEN few attempts to use multivariate methods for the prediction of prognosis in acute lymphoblastic leukaemia (ALL) though its value in thyroid cancer is well described (Byar et al., 1979) . Two previous papers (Gehan et al., 1976; Miller et al., 1978) have shown that it is possible to define groups of children with different risks of relapse, and thus to structure trials of treatment so that those at high risk have more intensive or novel treatment whilst those at low risk are treated less intensively. In this way, some patients may be spared short-term effects of treatment such as serious infection (Hughes, 1971 ) and long-term effects such as infertility (Lendon et al., 1978) whilst others at high risk may experience a better response.
We examined an unselected populationbased series of 209 children with ALL, to see whether we could define a risk score at diagnosis which would predict the outcome of treatment in those children who went into complete remission. The length of first remission was taken as the criterion of response, because of almost inevitable death following relapse in patients who have had full conventional therapy (Cornbleet & Chessells, 1978) . For 9 children who died while still in first remission, the criterion of response was the time from achieving complete remission to death.
PATIENTS AND METHODS
Two hundred and nine consecutive patients presenting between 1971 and 1977 with ALL to the Royal Manchester Children's Hospital Paediatric Oncology Unit were studied. These children, aged between 3 months and 16 years, represented about 95% of all children presenting with ALL in the region (Draper et al., 1980) . All received full conventional therapy with vincristine, prednisolone (with or without an anthracycline and/or L-asparaginase) for induction of remission. Cranial irradiation and intrathecal methotrexate or cranio-spinal irradiation were given, followed by 2-3 years' maintenance therapy, whcih always contained at least methotrexate and 6-mercaptopurine. The regimens were usually those in current Medical Research Council (UKALL) trials. The haematological, biochemical and radiological tests carried out have already been described (see Table I for references).
Details for each patient were put on to coding forms and after input to computer were analysed in two ways:
(1) The effect of each variable (age, sex, WBC etc.) was analysed individually by calculating Kaplan-Meier remission-duration curves, which were then compared using the logrank test (Peto et al., 1977) . For continuous variables, a convenient number of categories were first of all defined, and a logrank P value for trend calculated.
(2) A regression method (Cox, 1972) was used for the multivariate analysis of all variables which were significant on the logrank tests. Stepwise inclusion of the most significant variable was performed until the predictive capacity of the model (assessed by the increase in log-likelihood) was no longer statistically significant at the 5% level.
Details of the regression method and the calculation of the risk score for each patient appear in the Appendix.
RESULTS
Thirty-two variables at diagnosis which were studied individually are shown in Table I with the level of statistical significance for each. Twelve had a significant effect (P < 0.05) on the length of first remission. Time to achieve complete remission from the start of treatment was also statistically significant, but this was omitted from further analysis because this information was obviously not available at diagnosis. Table II .
It is interesting to note that the addition of age and low serum immunoglobulin level as further prognostic variables gave suggestions of possible correlation with duration of first remission. However, the correlations were not as strong as for the 3 variables already included and were not quite statistically significant (P = 0 06 and 0 15 respectively). Age and low serum immunoglobulin level were therefore not included as determinants of remission time. *Logarithrm was u.secl because of the very skewed distributions. Some children had no PAS+ lymphoblasts and logarithm of zero is impossible so 1 was added to these percentages before taking logarithms. gether (e.g. Bernard et al., 1975) and even acute myeloid leukaemia with ALL, despite the known differences between these diseases (Gehan et al., 1976) . We investigated an unselected populationbased group of children with ALL who received full conventional treatment. including CNS prophylaxis, at one institution under the care of one physician (PMJ). This study should reflect the heterogeneity of the disease and help to clear up much of the controversy over some prognostic factors.
Most published reports have shown that the prognostic factor of prime importance in ALL is a measurement of leukaemic mass, usually represented by the WBC and degree of organomegaly (Simone, 1975) . The association of these factors with each other is also well known, but the fact that other mass factors have no separate prognostic significance when correlations with WBC are taken into account has not been fully appreciated. We have shown that although hepatomegaly and splenomegaly achieve prognostic significance when assessed individually, they have no independent significance in a multivariate analysis which includes WBC. Immunological blast surface markers also have a significant effect on prognosis when examined in isolation in our series, and in others Chessells et al., 1977) , but this significance was not maintained in a multivariate analysis, because of the close association between T-cell disease and high WBC. Children with B-cell disease may well have very poor prognosis ) but there were too few patients in our series for separate analysis.
FAB classification
Various attempts have been made to classify ALL by morphological appearance (Mathe et al., 1973; Flandrin & Bernard, 1975) . The Franco-American-British classification (FAB, 1976) divides lymphoblasts into LI, L2 and L3 subtypes, the criteria being blast size as well as cytoplasmic and nuclear features. The L3 type corresponds to B-cell leukaemia, but there has been no consistent relationship between LI, L2 and other immunological subtypes (Tsukimoto et al., 1976) . We found the L2 subtype had larger blasts than LI and a higher percentage of cells in S phase (Hann et al., 1979a) . These patients may thus have a larger tumour growth fraction, and this may be the reason for the worse prognosis in the L2 subtype.
PAS score PAS score has previously been shown to be a significant factor in the prognosis of childhood ALL (Willoughby & Laurie, 1968; Lilleyman et al., 1979; Hann et al., 1979a) . We found an association between low PAS score, L2 subtype and mediastinal mass, providing further evidence of a "sarcomatous" type of leukaemia.
In spite of a correlation with WBC as well, the multivariate analysis showed that the percentage of lymphoblasts with PAS+ coarse granules and blocks was a significant determinant of remission duration which acted independently of other prognostic variables.
Risk score
We have constructed a simple risk score at diagnosis of childhood ALL based on the FAB classification, WBC, and % PAS+ coarse granules or blocks. This risk score accurately predicts the subsequent prognosis of children who achieve a complete remission while the categories for WBC (< 20x 109/1, 20-50x 109/1 and > 50 x 109/1) conform to the usual clinical subdivisions of this variable.
For routine clinical use it is probably preferable to combine patients with risk scores 4 and 5 into a single Group IV. The largest group, Group I, contains only about one third of children. The observed median duration of first remission varied from only 8 months in Group IV to more than 9 years in Group I. This remarkable 13-fold difference in prognosis is probably a little exaggerated, because the scoring system which is optimal for this series is unlikely to be optimal in other series.
However, when used in other series the predictive power of the score should still be very high.
Risk score in clinical trial design
There are 3 applications of our risk score in clinical trial design. Firstly, many trials in childhood ALL are designed specifically for "good-" or "bad-" prognosis patients, assignment usually being to the latter group if the WBC is over 20 x 109/1 or if mediastinal mass is present. Our results have shown however that the effect of a favourable or unfavourable WBC can be outweighed by other factors, and therefore a subdivision of patients based on the risk score would be more likely to produce groups consisting of patients with roughly the same prognosis.
The risk scores we have demonstrated should therefore be of value in idcentifying more accurately patients with good and bad prognosis for whom different trials may be designed; as when some poorprognosis patients might be randomized to receive novel types of treatment, while some good-prognosis patients might receive less-toxic therapy.
Secondly, greater comparability of treatment groups has been achieved in many trials through randomization stratified by important prognostic variables. If stratification is used at all, practical reasons usually restrict it to one or at the most 2 variables, whereas our analysis has shown that in childhood ALL 3 prognostic variables are required to explain all the significant variation in remission times. Because randomization stratified by risk group is equivalent to stratification by the 3 prognostic variables which comprise the risk score, it provides a simple and effective means of ensuring that treatment groups are as similar as possible in all important respects.
Lastly Each regression coefficient, ,B, in the equation reflects the net effect of the corresponding variable Z on the hazard function Ao(t) after the effects of all other variables have been accounted for. For each patient the value of Zl/l + Z2/2 + . . . + Zp/pp can be regarded as a "risk score", the higher the value the greater being the probability of relapse and the worse the prognosis.
Examination of the regression coefficients and variables in the risk-score equation suggested that a much simpler scoring system might have similar predictive power. It was found empirically that the simple risk score described in the text is for most children in the series the nearest integer to 1 + 1 6 x exact risk score, while the limits used for allocating children to the different risk groups conform to well established clinical subdivisions. The logrank x2 for trend obtained by comparing actual prognosis in the four risk groups was statistically highly significant (X2=61*07, d.f. = 1, P<000001) and was consistent with the overall increase in log-likelihood (30.87, X2=61-74, d.f.=3,P <000001) obtained in the multivariate regression analysis.
